Search - tctmd.com

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

Presenter: Gill Buchanan, Alaide Chieffo, Chiara Bernelli, Matteo Montorfano, Mauro Carlino, Azeem Latib, Filippo Figini, Irene Franzoni, Santo Ferrarello, Alfonso Ielasi, Francesco Sacco, Massimo Slavich, Alessandro Durante, Alfredo Castelli, Antonio Colombo

January 31, 2013

Presentation TCT 2013

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Presenter: Seung-Jin Oh, Armando Tellez, Maxwell Afari, Gerard Conditt, Jenn McGregor, Yanping Cheng, Geng-Hua Yi, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Serial Evaluation Of Peri-strut Low Intensity Area On Optical Coherence Tomography After Drug-eluting Stents Implantation

Presenter: Eui Im, Byeong-Keuk Kim, Jung-Sun Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong

January 31, 2013

Advertisement

TWENTE: Still Few Differences between ZES and EES at 2 Years

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Mortality Varies by Revascularization Method in Dialysis Patients

Los SLF de Rescate son Efectivos en Pacientes con ICE y Lesiones por Debajo de la Rodilla

Colchicine Reduces BMS Restenosis in Diabetic Patients

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

Drug-Eluting Stents: Past, Present, and Future

REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests

Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Medtronic Approved to Update Resolute Integrity Stent’s ‘CE’ Mark Labeling on Dual Antiplatelet Therapy

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Serial Evaluation Of Peri-strut Low Intensity Area On Optical Coherence Tomography After Drug-eluting Stents Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content